Furthermore, also an ongoing expression of SARS-CoV2 RNA and persistence of viral nucleocapsid protein in gut epithelia and CD8+ T cells has been demonstrated in many patients with inflammatory bowel disease (IBD) more than 7 months after mild acute COVID-19 infection [15]. The gene discussed is CD8A; the disease is inflammatory bowel disease.